Maven Securities LTD Fate Therapeutics Inc Transaction History

Maven Securities LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$59.27 - $95.73 $255,512 - $412,692	-4,311 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$67.25 - $92.52 $289,914 - $398,853	4,311 New	4,311 $389,000
Q4 2019 Feb 14, 2020	SELL	$13.39 - $20.73 $937,300 - $1.45 Million	-70,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$15.47 - $22.5 $1.08 Million - $1.58 Million	70,000 New	70,000 $1.09 Million
Q4 2018 Feb 14, 2019	SELL	$11.48 - $16.98 $643,144 - $951,270	-56,023 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$8.75 - $16.29 $490,201 - $912,614	56,023 New	56,023 $916,000

190

123M

15K

14K

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $311M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.